Tango Therapeutics (TNGX) Other Non-Current Assets (2020 - 2026)

Tango Therapeutics' Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $293000.0 for Q1 2026.

• On a quarterly basis, Other Non-Current Assets fell 88.73% year-over-year to $293000.0 in Q1 2026; TTM through Mar 2026 was $293000.0, a 88.73% decrease from a year earlier, with the FY2025 full-year figure at $303000.0, down 88.35% from the prior year.
• Other Non-Current Assets fell to $293000.0 in Q1 2026 per TNGX's latest filing, from $303000.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $4.0 million in Q1 2022 and bottomed at $290000.0 in Q3 2025.
• The 5-year median for Other Non-Current Assets is $2.6 million (2024), against an average of $2.7 million.
• Across the five-year window, Other Non-Current Assets soared 73.91% in 2022 and slumped 88.85% in 2025, its largest moves.
• Year by year, Other Non-Current Assets stood at $4.0 million in 2022, then retreated by 15.0% to $3.4 million in 2023, then slipped by 23.53% to $2.6 million in 2024, then sank by 88.35% to $303000.0 in 2025, then declined by 3.3% to $293000.0 in 2026.
• Per Business Quant, the three latest TNGX Other Non-Current Assets figures stand at $293000.0 (Q1 2026), $303000.0 (Q4 2025), and $290000.0 (Q3 2025).